Y. Tambe

发表

Female-specific rectal carcinogenesis in cyclin D1b transgenic mice.

H. Sugihara, H. Inoue, T. Isono, 2014, Carcinogenesis.

Influence of natural and synthetic compounds on cell surface expression of cell adhesion molecules, ICAM-1 and VCAM-1.

Y. Kashiwada, Y. Ikeshiro, M. Tabata, 2001, Planta medica.

The drs tumor suppressor is involved in the maturation process of autophagy induced by low serum.

A. Yamamoto, H. Inoue, T. Isono, 2009, Cancer letters.

Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs.

Y. Saga, S. Yamada, T. Hattori, 2006, Carcinogenesis.

A novel apoptotic pathway induced by the drs tumor suppressor gene

M. Yutsudo, H. Inoue, T. Isono, 2004, Oncogene.

Periostin suppresses in vivo invasiveness via PDK1/Akt/mTOR signaling pathway in a mouse orthotopic model of bladder cancer

A. Kawauchi, H. Sugihara, H. Inoue, 2017, Oncology letters.

Suppression of viral replication by drs tumor suppressor via mTOR dependent pathway.

H. Inoue, T. Chano, Y. Tambe, 2012, Cancer letters.

Function of Tumor Suppressor Gene, drs

H. Inoue, Y. Tambe, 2013 .

Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene.

Y. Ikeshiro, Y. Tambe, S. Tanaka, 1996, Planta medica.

Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.

A. Kawauchi, H. Sugihara, H. Inoue, 2017, International journal of oncology.

Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells.

H. Inoue, C. Kim, Y. Tambe, 2011, International journal of oncology.

Role of alternative splicing of periostin in human bladder carcinogenesis.

H. Inoue, T. Isono, H. Okabe, 2008, International journal of oncology.

Periostin is down‐regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells

N. Yoshioka, H. Inoue, R. Kushima, 2005, International journal of cancer.

Suppression of Viral Replication by Stress-Inducible GADD34 Protein via the Mammalian Serine/Threonine Protein Kinase mTOR Pathway

K. Isobe, O. Hino, H. Inoue, 2007, Journal of Virology.

Downregulation of drs mRNA expression is associated with the progression of adult T-cell leukemia/lymphoma.

M. Yutsudo, K. Ohshima, H. Inoue, 2007, International journal of oncology.

GADD34 inhibits mammalian target of rapamycin signaling via tuberous sclerosis complex and controls cell survival under bioenergetic stress.

K. Isobe, O. Hino, H. Inoue, 2007, International journal of molecular medicine.

Akt-dependent activation of Erk by cyclin D1b contributes to cell invasiveness and tumorigenicity.

A. Kawauchi, H. Sugihara, H. Inoue, 2016, Oncology letters.

Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells

H. Inoue, T. Isono, K. Nishi, 2009, Molecular carcinogenesis.

Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β-catenin/N-cadherin axis

A. Kawauchi, H. Inoue, K. Mukaisho, 2021, International journal of oncology.

The drs tumor suppressor regulates glucose metabolism via lactate dehydrogenase‐B

A. Yamamoto, H. Inoue, C. Kim, 2016, Molecular carcinogenesis.

Molecular Carcinogenesis

Hiroyuki Tanaka, T. Terado, J. Chida, 2019 .

Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.

A. Kawauchi, H. Sugihara, H. Inoue, 2017, International journal of oncology.

Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells.

H. Inoue, C. Kim, Y. Tambe, 2011, International journal of oncology.